Journal of Scientific Papers

ECONOMICS & SOCIOLOGY


© CSR, 2008-2019
ISSN 2071-789X

3.1
2019CiteScore
 
91th percentile
Powered by  Scopus



Directory of Open Access Journals (DOAJ)


Strike Plagiarism

Partners
  • General Founder and Publisher:

     
    Centre of Sociological Research

     

  • Publishing Partners:

     

    The journal is co-financed in the years 2022-2024 by the Ministry of Education and Science of the Republic of Poland in the framework of the ministerial programme “Development of Scientific Journals” (RCN) on the basis of contract no. RCN/SN/0668/2021/1 


    University of Szczecin (Poland)

    Széchenyi István University, (Hungary)

    Mykolas Romeris University (Lithuania)

    Alexander Dubcek University of Trencín (Slovak Republic)


  • Membership:

     

    Society for Scholarly Publishing (SSP)

    American Sociological Association


    European Sociological Association


    World Economics Association (WEA)

     


    CrossRef

     


MANAGING PUBLIC HEALTHCARE UNITS IN POLAND – RESEARCH FINDINGS

Vol. 4, No 1a, 2011

 

 

 

 HEALTH TECHNOLOGY ASSESSMENT – IS IT THE WAY TO SEARCH FOR COST – EFFECTIVE MEDICINES IN CENTRAL AND EASTERN EUROPE?

 Marcin Czech

 

Abstract. Health Technology Assessment (HTA) is a multidisciplinary process that summarizes information about medical, social, economic and ethical issues related to the use of a health technology in a systematic, transparent, unbiased, robust manner. HTA constitutes an integral part of a decision making process covering, among others, pricing and reimbursement of drugs and medical devices in Central and Eastern Europe.

In this review I describe the main definitions and elements of HTA placed in a context of healthcare systems’ reforms with a special emphasis on budget control tools in the Region. I also give information on some model solutions, brief history, main limitations, challenges and conditions of further development of the domain, together with some discussion from the pharmaceutical industry’s perspective.

 

Keywords:Health Technology Assessment, HTA, Pharmacoeconomics, Central and Eastern Europe, Evidence – Based Medicine.

 

JEL Classification: I180.


References

1. Auray J-P., Beresniak A., Claveranne J-P., Duru D.: Dictionnaire commente d’economie de la sante Masson, Paris 1996.

2. Bootman, J.L., Townsend, R.J. McGhan, W.F.: Principles of Pharmacoeconomics. 2nd edition, New York, 1996, Harvey Whitney Book Company.

3. Carlson JJ, Garrison LP Jr, Sullivan SD. Paying for outcomes: innovative coverage and reimbursement schemes for pharmaceuticals. JManag Care Pharm 2009 Oct; 15 (8): 683-7.

4.National Institute for Health and Clinical Excellence Web Page http://www.nice.org.uk/aboutnice/whoweare

/structureofnice/structure_of_nice.jsp accessed 05.2010

5. Kristensen F.B.: EUnetHTA and health policy-making in Europe. Eurohealth 2006, 12(1), 36-38.

6. Moher D, Tetzlaff J, Tricco AC, Sampson M, Altman DG (2007). "Epidemiology and reporting characteristics of systematic reviews". PLoS Med. 4 (3).


Marcin Czech, MD, Associate Professor

Department of Pharmacoeconomics

Faculty of Pharmacy

Medical University of Warsaw

Poland

marcin.czech@wum.edu.pl